MA26556A1 - Derive d'indole utile en therapeutique, procede pour sa production et formulation pharmaceutique le contenant. - Google Patents

Derive d'indole utile en therapeutique, procede pour sa production et formulation pharmaceutique le contenant.

Info

Publication number
MA26556A1
MA26556A1 MA25307A MA25307A MA26556A1 MA 26556 A1 MA26556 A1 MA 26556A1 MA 25307 A MA25307 A MA 25307A MA 25307 A MA25307 A MA 25307A MA 26556 A1 MA26556 A1 MA 26556A1
Authority
MA
Morocco
Prior art keywords
therapeutics
production
same
pharmaceutical formulation
formulation containing
Prior art date
Application number
MA25307A
Other languages
English (en)
Inventor
Challenger Stephen
Michael Derrick Andrew
Ellis David
James Kim
James Rawson David
Neil Dack Kevin
Hajikarimian Yousef
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MA26556A1 publication Critical patent/MA26556A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MA25307A 1997-10-22 1998-10-21 Derive d'indole utile en therapeutique, procede pour sa production et formulation pharmaceutique le contenant. MA26556A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9722287.1A GB9722287D0 (en) 1997-10-22 1997-10-22 Compounds useful in therapy

Publications (1)

Publication Number Publication Date
MA26556A1 true MA26556A1 (fr) 2004-12-20

Family

ID=10820904

Family Applications (1)

Application Number Title Priority Date Filing Date
MA25307A MA26556A1 (fr) 1997-10-22 1998-10-21 Derive d'indole utile en therapeutique, procede pour sa production et formulation pharmaceutique le contenant.

Country Status (17)

Country Link
US (1) US6211223B1 (fr)
AP (1) AP899A (fr)
AR (1) AR014922A1 (fr)
AU (1) AU1150999A (fr)
BG (1) BG104394A (fr)
CA (1) CA2308478C (fr)
CZ (1) CZ20001514A3 (fr)
DZ (1) DZ2628A1 (fr)
GB (1) GB9722287D0 (fr)
GT (1) GT199800161A (fr)
MA (1) MA26556A1 (fr)
MY (1) MY117148A (fr)
PA (1) PA8461001A1 (fr)
TN (1) TNSN98190A1 (fr)
TW (1) TW483893B (fr)
WO (1) WO1999020623A1 (fr)
ZA (1) ZA989574B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9722287D0 (en) 1997-10-22 1997-12-17 Pfizer Ltd Compounds useful in therapy
AR037097A1 (es) 2001-10-05 2004-10-20 Novartis Ag Compuestos acilsulfonamidas, composiciones farmaceuticas y el uso de dichos compuestos para la preparacion de un medicamento
CN106631920B (zh) * 2016-11-17 2018-11-13 贵州大学 一种2-羟基-4-甲基苯磺酸的制备方法
CN114507162A (zh) * 2020-11-16 2022-05-17 尚科生物医药（上海）有限公司 一种制备2-氟-5-甲氧基苯磺酰氯的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0617001B1 (fr) * 1993-03-19 2000-01-26 Merck & Co. Inc. Dérivés d'acide phénoxyphénylacétique
GB9609641D0 (en) * 1996-05-09 1996-07-10 Pfizer Ltd Compounds useful in therapy
GB9722287D0 (en) 1997-10-22 1997-12-17 Pfizer Ltd Compounds useful in therapy

Also Published As

Publication number Publication date
PA8461001A1 (es) 2000-05-24
ZA989574B (en) 2000-04-25
AR014922A1 (es) 2001-04-11
CA2308478A1 (fr) 1999-04-29
TNSN98190A1 (fr) 2005-03-15
BG104394A (en) 2001-09-28
AP9801370A0 (en) 1998-12-31
CA2308478C (fr) 2004-12-07
TW483893B (en) 2002-04-21
US6211223B1 (en) 2001-04-03
CZ20001514A3 (cs) 2001-09-12
WO1999020623A1 (fr) 1999-04-29
AP899A (en) 2000-11-17
DZ2628A1 (fr) 2003-03-08
GB9722287D0 (en) 1997-12-17
AU1150999A (en) 1999-05-10
GT199800161A (es) 2000-04-11
MY117148A (en) 2004-05-31

Similar Documents

Publication Publication Date Title
MA26508A1 (fr) Formulations pharmaceutiques contenant du variconazole, et procede pour leur preparation.
MA26516A1 (fr) Tartrate d'un dipeptide substitue, procede pour sa preparation et compositions pharmaceutiques le contenant.
MA26439A1 (fr) Derives d'indazole nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26472A1 (fr) Derives de n-hydroxy-b-sulfonylpropionamide, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26424A1 (fr) Derives de 6-phenylpyridyl-2-amine, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26687A1 (fr) 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinoleines, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26614A1 (fr) Bicyclo [2.2.1] heptanes nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26414A1 (fr) Derives de quinoleine et de quinazoline nouveaux, procede pour leur preparation et formulations pharmaceutiques les contenant.
FR2740136B1 (fr) Derives d'indolin-2-one, procede pour leur preparation et les compositions pharmaceutiques les contenant
MA26451A1 (fr) Amides inhibiteurs de secretion de apo b/mtp, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26526A1 (fr) Derives d'indole inhibiteurs de cyclo-oxygenase, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26499A1 (fr) Derives de tetrazole, procede pour leur preparation et compositions pharmaceutiques les contenant .
MA26630A1 (fr) 4-phenylpyperidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2780057B1 (fr) Phenoxypropanolamines, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26562A1 (fr) Composes therapeutiquement actifs bases sur le remplacement bio-isosterique du catechol par l'indazole dans des inhibiteurs de pde4, leur procede de production et composition pharmaceutique les contenant.
MA26410A1 (fr) Formulations pharmaceutiques et procede pour leur production.
MA26428A1 (fr) Derives d'indole nouveaux, procede pour leur preparation et formulations pharmaceutiques les contenant
MA26430A1 (fr) 4 (3h)-quinazolinones 2,3-disubstituees nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
MA23942A1 (fr) Formulation nouvelle contenant de la paroxetine, et procede pour sa preparation
MA26433A1 (fr) Derives de pyridylpyrrole, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2636628B1 (fr) Derives du thiadiazole-1,3,4, leur procede d'obtention et compositions pharmaceutiques en contenant
MA26552A1 (fr) Derives d'isoquinoleine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26417A1 (fr) Azetidines, procede pour leur preparation, et compositions pharmaceutiques les contenant
FR2663326B2 (fr) Derives de la pyridazine, procede de preparation et compositions pharmaceutiques en contenant.
FR2687401B1 (fr) Derives de la 1,4-dialkylpiperazine, procedes d'obtention et compositions pharmaceutiques les contenant.